Calendar Teva Pharmaceutical Industries Limited TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Chart calendar Teva Pharmaceutical Industries Limited
Upcoming events on Teva Pharmaceutical Industries Limited
Past events on Teva Pharmaceutical Industries Limited
2024-06-11 08:00 am | Goldman Sachs Global Healthcare Conference |
2024-06-06 09:00 am | Annual General Meeting |
2024-05-14 11:40 am | BofA Securities Health Care Conference |
2024-05-08 08:00 am | Q1 2024 Earnings Call |
2024-05-08 07:00 am | Q1 2024 Earnings Release |
2024-04-02 | Schizophrenia International Research Society Congress |
2024-01-31 08:00 am | Q4 2023 Earnings Call |
2024-01-31 07:00 am | Q4 2023 Earnings Release |
2024-01-08 11:15 am | JPMorgan Healthcare Conference |
2023-11-28 08:20 am | Evercore ISI HealthCONx Conference |
2023-11-08 08:00 am | Q3 2023 Earnings Call |
2023-11-08 07:00 am | Q3 2023 Earnings Release |
2023-11-01 | Huntington Study Group Meeting |
2023-10-04 08:00 am | Sanofi Pharmaceutical Industry Company and Teva Pharmaceutical Industries Ltd Collaboration Agreemen |
2023-09-11 08:40 am | Morgan Stanley Global Healthcare Conference |
2023-09-09 03:00 pm | Psych Congress |
2023-09-07 | Psych Congress - Poster #104 |
2023-09-07 | Psych Congress - Poster #130 |
2023-09-07 | Psych Congress - Poster #90 |
2023-09-07 | Psych Congress - Poster #134 |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 16 887 17 254 -2.13% | 16 659 16 599 0.36% | 15 878 16 125 -1.53% | 14 925 14 952 -0.18% | 15 846 15 349 3.24% | 16 002 |
EBITDA Million USD | Released Forecast Spread | 4 685 4 678 0.16% | 4 912 4 899 0.26% | 4 911 4 862 1.01% | 4 598 4 702 -2.22% | 4 818 4 520 6.58% | 4 769 |
EBIT Million USD | Released Forecast Spread | 4 142 4 108 0.82% | 4 388 4 333 1.27% | 4 401 4 355 1.05% | 4 139 4 163 -0.57% | 4 361 4 050 7.67% | 4 285 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -1 265 1 262 -200.22% | -4 406 1 060 -515.66% | 658 1 625 -59.51% | 0,00 0,00 - | -624 -916 31.88% | -99,0 |
Net income Million USD | Released Forecast Spread | -999 -806 -23.87% | -3 990 -3 864 -3.27% | 417 954 -56.3% | -2 353 -494 -375.86% | -559 343 -262.9% | 809 |
EPS USD | Released Forecast Spread | -0,91 -0,73 -23.86% | -3,64 -3,48 -4.56% | 0,38 0,76 -50.04% | -2,12 -0,45 -370.01% | -0,50 -0,24 -107.75% | 0,96 |
Announcement Date | 12/02/20 | 10/02/21 | 09/02/22 | 08/02/23 | 31/01/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 3 661 3 754 -2.48% | 3 786 3 775 0.29% | 3 595 3 854 -6.72% | 3 884 3 905 -0.54% | 3 661 3 589 2% | 3 878 3 720 4.24% | 3 850 3 736 3.05% | 4 457 4 010 11.15% | 3 819 3 740 2.12% | 4 040 | 4 039 | 4 109 | 3 845 | 3 976 |
EBITDA Million USD | Released Forecast Spread | 1 135 1 096 3.54% | 1 134 1 138 -0.39% | 1 089 1 181 -7.77% | 1 240 1 332 -6.93% | 899 1 119 -19.69% | 1 125 1 079 4.22% | 1 134 1 186 -4.41% | 1 660 1 394 19.06% | 1 005 1 049 -4.18% | 1 137 | 1 220 | 1 361 | ||
EBIT Million USD | Released Forecast Spread | 1 013 976 3.84% | 1 019 1 012 0.67% | 977 1 048 -6.8% | 1 130 1 165 -3.02% | 785 984 -20.19% | 1 011 956 5.8% | 1 020 1 063 -4.04% | 1 546 1 251 23.56% | 892 920 -3.09% | 1 027 | 1 108 | 1 211 | 949 | 1 091 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -971 403 -340.94% | -1 160 393 -395.17% | -1 100 430 -355.81% | 75,0 443 -83.07% | 507 180 181.67% | -467 141 -431.21% | 107 | 127 | 133 | |||||
Net income Million USD | Released Forecast Spread | -955 335 -384.9% | -232 236 -198.45% | 56,0 96,7 -42.1% | -1 221 584 -309.12% | -205 58,2 -452.48% | -863 -12,2 -6951.9% | 80,0 -192 141.73% | 461 1 055 -56.3% | -139 32,0 -534.38% | 39,0 | 56,5 | -15,8 | ||
EPS USD | Released Forecast Spread | -0,86 0,28 -404.92% | -0,21 0,06 -475.6% | 0,05 0,09 -42.12% | -1,10 0,50 -319.89% | -0,18 0,05 -447.89% | -0,77 -0,01 -7023.03% | 0,07 -0,35 119.73% | 0,41 0,53 -21.99% | -0,12 -0,05 -148.76% | -0,40 | 0,00 | 0,90 | ||
Announcement Date | 03/05/22 | 26/07/22 | 03/11/22 | 08/02/23 | 10/05/23 | 02/08/23 | 08/11/23 | 31/01/24 | 08/05/24 | - | - | - | - | - |
2024-07-15 | CAMURUS AB: Q2 2024 Earnings Release |
2024-07-16 | GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-17 06:45 am | JOHNSON & JOHNSON: Q2 2024 Earnings Release |
2024-07-17 | JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-18 01:00 am | NOVARTIS AG: Q2 2024 Earnings Release |
2024-07-18 | TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release |
2024-07-21 | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-21 | ALMIRALL, S.A.: Q2 2024 Earnings Release |
2024-07-22 | TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected) |
2024-07-23 | INNOVIVA, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Teva Pharmaceutical Industries Limited
2024-07-10 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release |
2024-07-09 | LOTUS PHARMACEUTICAL CO., LTD.: June 2024 Sales and Revenue Release |
2024-07-09 07:35 am | SCINOPHARM TAIWAN, LTD.: June 2024 Sales and Revenue Release |
2024-07-03 | HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected) |
2024-07-02 05:05 am | ONENESS BIOTECH CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-21 11:28 am | DEVA HOLDING: Q1 2024 Earnings Release |
2024-06-13 05:21 pm | EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release |
2024-06-11 01:30 am | BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release |
2024-06-07 06:33 am | SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release |
2024-06-07 05:17 am | LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release |